U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C28H40N2O5.ClH
Molecular Weight 521.089
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of GALLOPAMIL HYDROCHLORIDE

SMILES

Cl.COC1=CC(=CC(OC)=C1OC)C(CCCN(C)CCC2=CC(OC)=C(OC)C=C2)(C#N)C(C)C

InChI

InChIKey=OKCRIUNHEQSXFD-UHFFFAOYSA-N
InChI=1S/C28H40N2O5.ClH/c1-20(2)28(19-29,22-17-25(33-6)27(35-8)26(18-22)34-7)13-9-14-30(3)15-12-21-10-11-23(31-4)24(16-21)32-5;/h10-11,16-18,20H,9,12-15H2,1-8H3;1H

HIDE SMILES / InChI

Molecular Formula C28H40N2O5
Molecular Weight 484.6276
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Gallopamil is a L-type calcium channel blocker designed for the treatment of coronary heart diseases: angina pectoris, prinzmetal angina and hypertonia.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
5.0 µM [IC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
PROCORUM

Approved Use

Unknown
Primary
PROCORUM

Approved Use

Unknown
Primary
PROCORUM

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
The effect of a calcium antagonist (D600) on isoprenaline-induced myocardial necrosis in the rat.
1979 Jun
[Anti-angina effect of gallopamil in comparison with another calcium antagonist and a placebo].
1984 Sep
A comparison of nine calcium ion antagonists and propranolol: exercise tolerance, heart rate and ST-segment changes in patients with chronic stable angina pectoris.
1987
Beta-adrenergic agonists stimulate the oxidative pentose phosphate pathway in the rat heart.
1990 Dec
Effects of gallopamil, a Ca2+ channel blocker in models of ventricular arrhythmia in dogs.
1993 Feb 16
Affinities at the verapamil binding site of MDR1-encoded P-glycoprotein: drugs and analogs, stereoisomers and metabolites.
2000 Apr
Quantitative distinctions of active site molecular recognition by P-glycoprotein and cytochrome P450 3A4.
2001 Dec
Calcium transients in subcompartments of the leech Retzius neuron as induced by single action potentials.
2001 Jul
Left-to-right gradient of atrial frequencies during acute atrial fibrillation in the isolated sheep heart.
2001 May 29
Initial and sustained phases of myogenic response of rat mesenteric small arteries.
2001 Nov
A randomized prospective double-blind placebo-controlled study of gallopamil, calcium antagonist of the verapamil type, in stable cyclosporine-treated renal transplant recipients.
2002 Aug
[L-type calcium channels involvement in aortic smooth muscle contraction as revealed by membrane potential and active force dynamics].
2004 Apr-Jun
Opposite effects of a single IIIS5 mutation on phenylalkylamine and dihydropyridine interaction with L-type Ca2+ channels.
2004 Dec 31
Multidimensional on-line sample preparation of verapamil and its metabolites by a molecularly imprinted polymer coupled to liquid chromatography-mass spectrometry.
2004 Mar 5
An ionic model for rhythmic activity in small clusters of embryonic chick ventricular cells.
2005 Jul
Block of TRPC5 channels by 2-aminoethoxydiphenyl borate: a differential, extracellular and voltage-dependent effect.
2005 Jun
Insulin stimulates Ca2+ uptake via PKC, cAMP, and p38 MAPK in mouse embryonic stem cells.
2005 May 6
Nitric oxide involvement in pancreatic beta cell apoptosis by glibenclamide.
2006 Feb
Endogenous alkaline transients boost postsynaptic NMDA receptor responses in hippocampal CA1 pyramidal neurons.
2007 Jul 11
Effects of phenylalkylamines and benzothiazepines on Ca(v)1.3-mediated Ca2+ currents in neonatal mouse inner hair cells.
2007 Nov 14
Formation of DNA-damaging N-nitroso compounds from the interaction of calcium-channel blockers with nitrite.
2007 Sep 5
Mechanisms of potassium- and capsaicin-induced axonal calcitonin gene-related peptide release: involvement of L- and T-type calcium channels and TRPV1 but not sodium channels.
2008 Feb 6
Positive inotropic effects of epigallocatechin-3-gallate (EGCG) involve activation of Na+/H+ and Na+/Ca2+ exchangers.
2008 May
Development of a list of potentially inappropriate drugs for the korean elderly using the delphi method.
2010 Dec
Patents

Sample Use Guides

In Vivo Use Guide
150 mg/day
Route of Administration: Oral
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:12:47 UTC 2023
Edited
by admin
on Fri Dec 15 15:12:47 UTC 2023
Record UNII
VT4VR32A0T
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
GALLOPAMIL HYDROCHLORIDE
JAN   MART.   MI   WHO-DD  
Common Name English
5-(3,4-DIMETHOXYPHENETHYL) METHYLAMINO-2-ISOPROPYL-2-(3,4,5-TRIMETHOXYPHENYL)-VALERONITRILE HYDROCHLORIDE
Systematic Name English
.ALPHA.-ISOPROPYL-.ALPHA.-((N-METHYL-N-HOMOVERATRYL)-.GAMMA.-AMINOPROPYL)-3,4,5-TRIMETHOXYPHENYLACETONITRILE HYDROCHLORIDE
Common Name English
.ALPHA.-(3-((2-(3,4-DIMETHOXYPHENYL)ETHYL)METHYLAMINO)PROPYL)-3,4,5-TRIMETHOXY-.ALPHA.-(1-METHYLETHYL)BENZENEACETONITRILE HYDROCHLORIDE
Systematic Name English
GALLOPAMIL HCL
Common Name English
NSC-274966
Code English
D-600 HYDROCHLORIDE
Code English
Gallopamil hydrochloride [WHO-DD]
Common Name English
PROCORUM
Brand Name English
GALLOPAMIL HYDROCHLORIDE [MI]
Common Name English
GALLOPAMIL HYDROCHLORIDE [MART.]
Common Name English
ALGOCOR
Brand Name English
GALLOPAMIL HYDROCHLORIDE [JAN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C333
Created by admin on Fri Dec 15 15:12:47 UTC 2023 , Edited by admin on Fri Dec 15 15:12:47 UTC 2023
Code System Code Type Description
CAS
56949-75-8
Created by admin on Fri Dec 15 15:12:47 UTC 2023 , Edited by admin on Fri Dec 15 15:12:47 UTC 2023
SUPERSEDED
RXCUI
439837
Created by admin on Fri Dec 15 15:12:47 UTC 2023 , Edited by admin on Fri Dec 15 15:12:47 UTC 2023
PRIMARY RxNorm
CAS
16662-46-7
Created by admin on Fri Dec 15 15:12:47 UTC 2023 , Edited by admin on Fri Dec 15 15:12:47 UTC 2023
PRIMARY
NSC
274966
Created by admin on Fri Dec 15 15:12:47 UTC 2023 , Edited by admin on Fri Dec 15 15:12:47 UTC 2023
PRIMARY
NCI_THESAURUS
C83726
Created by admin on Fri Dec 15 15:12:47 UTC 2023 , Edited by admin on Fri Dec 15 15:12:47 UTC 2023
PRIMARY
FDA UNII
VT4VR32A0T
Created by admin on Fri Dec 15 15:12:47 UTC 2023 , Edited by admin on Fri Dec 15 15:12:47 UTC 2023
PRIMARY
ECHA (EC/EINECS)
240-704-7
Created by admin on Fri Dec 15 15:12:47 UTC 2023 , Edited by admin on Fri Dec 15 15:12:47 UTC 2023
PRIMARY
DRUG BANK
DBSALT002564
Created by admin on Fri Dec 15 15:12:47 UTC 2023 , Edited by admin on Fri Dec 15 15:12:47 UTC 2023
PRIMARY
PUBCHEM
119442
Created by admin on Fri Dec 15 15:12:47 UTC 2023 , Edited by admin on Fri Dec 15 15:12:47 UTC 2023
PRIMARY
MERCK INDEX
m5656
Created by admin on Fri Dec 15 15:12:47 UTC 2023 , Edited by admin on Fri Dec 15 15:12:47 UTC 2023
PRIMARY Merck Index
EPA CompTox
DTXSID2047858
Created by admin on Fri Dec 15 15:12:47 UTC 2023 , Edited by admin on Fri Dec 15 15:12:47 UTC 2023
PRIMARY
SMS_ID
100000092331
Created by admin on Fri Dec 15 15:12:47 UTC 2023 , Edited by admin on Fri Dec 15 15:12:47 UTC 2023
PRIMARY
EVMPD
SUB02309MIG
Created by admin on Fri Dec 15 15:12:47 UTC 2023 , Edited by admin on Fri Dec 15 15:12:47 UTC 2023
PRIMARY
Related Record Type Details
ENANTIOMER -> RACEMATE
ENANTIOMER -> RACEMATE
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY